tiprankstipranks
Advertisement
Advertisement

Hester Biosciences to Shut Trading Window Ahead of FY26 Results

Story Highlights
  • Hester Biosciences will close its trading window from 1 April 2026, reopening 48 hours after FY26 results become public.
  • The move aligns with SEBI insider trading rules and signals Hester’s focus on strong governance and investor protection.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Hester Biosciences to Shut Trading Window Ahead of FY26 Results

Meet Samuel – Your Personal Investing Prophet

Hester Biosciences Limited ( (IN:HESTERBIO) ) has provided an announcement.

Hester Biosciences Limited has announced that its trading window for dealing in the company’s equity shares will be closed from 1 April 2026. The window will reopen 48 hours after the financial results for the quarter and year ended 31 March 2026 are made publicly available, in line with SEBI’s insider trading regulations and the company’s internal code of conduct.

This measure is intended to prevent trading based on unpublished price-sensitive information by directors, promoters, designated employees and connected persons. The announcement underscores the company’s adherence to regulatory standards on insider trading, providing assurance to investors and other stakeholders about its corporate governance practices.

More about Hester Biosciences Limited

Hester Biosciences Limited operates in the biosciences sector, focusing on animal health and related biological products. The company is listed on both BSE and the National Stock Exchange of India, with its equity shares actively traded under the symbol HESTERBIO.

Average Trading Volume: 315

Technical Sentiment Signal: Sell

Current Market Cap: 11.75B INR

For an in-depth examination of HESTERBIO stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1